This Biotech Startup Just Raised $255 Million To Make Its AI-Designed Drug A Reality

While many AI biotech companies are on journeys to discover new drug targets, Hong Kong-based Insilico Medicine is a step ahead. The startup not only scouts for new drug sites using its AI and deep …
( read original story …)

---